Kava (Piper methysticum) is a traditional and culturally significant Pacific Island beverage that produces a soporific relaxant effect. Kava’s psychopharmacological action is similar to the anti-anxiety drug Benzodiazepine. Traditional users often consume the kava drink at volumes as much as 30 times greater than pharmacologically recommended doses. Prompted by concerns regarding driver impairment post kava drinking, a study was undertaken replicating traditional kava sessions in terms of duration and kava consumption, to investigate the effects of kava on driving capability.

META DATA

Creator | Kaihanga
Dr Apo Aporosa
Year of Creation | Tau
31/07/2018
Publisher | Kaiwhakaputa
Health Research Council of New Zealand
Creative Commons Licence
Attribution-NonCommercial-NoDerivatives CC BY-NC-ND
Main Language | Reo Matua
English
Submitter's Rights | Nga Tika o te Kaituku
I represent the publisher or owner organisation of this resource
Bibliographic Citation | Whakapuakanga

Aporosa, S. A. (2018). Improving road safety and health: Understanding kava’s impact on driver fitness. Technical report prepared (and accepted) for Health Research Council of New Zealand, July 31.

Back to top